Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Geburtshilfe Und Frauenheilkunde|January 14, 2022
Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic LesionsMichelle Wetzk, Nannette Grübling, Almuth Forberger, et al.
Cell Communication and Signaling : CCS|February 15, 2023
Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic originIlker A Deniz, Jana Karbanová, Manja Wobus, et al.
Oncotarget|April 19, 2017
EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapyIssam Chebouti, Sabine Kasimir-Bauer, Paul Buderath, et al.
International Journal of Cancer|September 12, 2019
Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancerTheresa Link, Simon Passek, Pauline Wimberger, et al.
BMC Cancer|July 31, 2020
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancerAndy Göbel, Valentina M Zinna, Stefania Dell'Endice, et al.
Frontiers in Immunology|November 12, 2025
Multi-compartment immune cell profiling highlights the prognostic relevance of CD127+ CD8+ T cells for patients with high-grade serous ovarian cancerRebecca Rothe, Antje Tunger, Theresa Link, et al.
Gynecologic Oncology|April 10, 2014
Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevancePauline Wimberger, Issam Chebouti, Sabine Kasimir-Bauer, et al.
Clinical Chemistry|November 12, 2013
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancerJan Dominik Kuhlmann, Alexander Baraniskin, Stephan A Hahn, et al.
Clinical Chemistry and Laboratory Medicine|November 14, 2018
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistanceJan Dominik Kuhlmann, Issam Chebouti, Rainer Kimmig, et al.
Genes, Chromosomes & Cancer|May 13, 2011
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapyJan Dominik Kuhlmann, Heidi Schwarzenbach, Friedrich Otterbach, et al.
Pageof 6